TASE:NVLGHealthcare
Novolog (TASE:NVLG) Profitability Reliant On ₪4.5m One Off Gain In FY 2025 Q3
Novolog (Pharm-Up 1966) (TASE:NVLG) has reported its FY 2025 third quarter with revenue of ₪483.6 million and basic EPS of ₪0.0077, alongside net income excluding extra items of ₪4.0 million. The trailing 12 month figures show revenue of ₪1.97 billion and basic EPS of ₪0.0243. Over recent quarters, revenue has moved between ₪441.7 million and ₪689.9 million, while quarterly basic EPS has ranged from ₪0.0020 to ₪0.0260. This gives investors a clearer view of how headline growth is feeding...